Publications by authors named "Hakan Ozgur"
Purpose: Trastuzumab, the HER2 oncogene targeting drug, shows remarkable clinical efficacy in HER2-amplified breast cancer patients. Despite of robust activity, some of the patients with HER2-positive breast cancers do not get the benefit due to trastuzumab resistance. Overexpression of p95HER2 is one of the molecular mechanisms of trastuzumab resistance.
View Article and Find Full Text PDFArticle Synopsis
- Anogenital mammary-like glands can develop various pathological lesions similar to those found in breast pathology, although tumors in this region are quite rare.
- A case study of a 28-year-old woman with a painless mass led to the discovery of a benign phyllodes tumor during microscopic examination.
- The report highlights the need to recognize these uncommon lesions in unusual locations, discussing their potential origins and reviewing existing literature on similar cases.